SINGAPORE: Global investment firm Hillhouse is emerging as one of the final few bidders for Everlife Holdings in a deal that could value the Asian healthcare services company at up to US$1bil, two people with knowledge of the matter say.
The deadline of the final binding bid for Everlife, which offers products and solutions to clinical and scientific laboratories in South and South-East Asia, is Jan 31, according to one of the sources.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
